CD8A and glioblastoma: In a set of 39 primary and recurrent GBM patients, Sayour et al. (76) discovered that while the absolute number of tumor infiltrating T cells may not be informative in predicting clinical outcome, the ratio of CD8+ T cells to Treg cells positively correlates with clinical outcome.